Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) Return on Invested Capital: 2022-2024

Historic Return on Invested Capital for Prime Medicine (PRME) over the last 1 years, with Jun 2024 value amounting to -1.01%.

  • Prime Medicine's Return on Invested Capital fell 42.00% to -1.01% in Q2 2024 from the same period last year, while for Jun 2024 it was -1.01%, marking a year-over-year decrease of 42.00%. This contributed to the annual value of -0.91% for FY2023, which is 54.00% up from last year.
  • As of Q2 2024, Prime Medicine's Return on Invested Capital stood at -1.01%, which was up 10.21% from -1.13% recorded in Q1 2024.
  • In the past 5 years, Prime Medicine's Return on Invested Capital ranged from a high of 0.64% in Q2 2022 and a low of -2.48% during Q4 2022.
  • Its 3-year average for Return on Invested Capital is -0.84%, with a median of -0.81% in 2023.
  • Data for Prime Medicine's Return on Invested Capital shows a maximum YoY tumbled of 123bps (in 2023) over the last 5 years.
  • Over the past 3 years, Prime Medicine's Return on Invested Capital (Quarterly) stood at -2.48% in 2022, then slumped by 123bps to -0.81% in 2023, then crashed by 42bps to -1.01% in 2024.
  • Its Return on Invested Capital stands at -1.01% for Q2 2024, versus -1.13% for Q1 2024 and -0.81% for Q3 2023.